Tessenderlo Group (ENXTBR:TESB) Stock Rebounds With Profit Back Yet Debt Questions Persist

Tessenderlo Group walked into this earnings day with a slowly recovering share price and a stock still framed as a valuation story, trading at a low price to sales multiple and well below one reference fair value estimate. The headline today is that the chemicals and industrial group has put profit back on the table in H1 2026, with around €1.5b in revenue and about €66m in net income after recent losses.

Love the return to profit at Tessenderlo Group but concerned it could still be a value trap story? Benchmark this earnings rebound against 266 high quality undervalued stocks

H1 2026 Earnings Summary

• Revenue (H1 2026 vs. H1 2025): €1,493.5m vs. €1,487.4m (broadly stable year on year)
• Net Income (Excl. Extra Items, H1 2026 vs. H1 2025): profit of €66.1m vs. loss of €9.5m (returned to positive earnings)
• Basic EPS (H1 2026 vs. H1 2025): €1.12 per share vs. loss of €0.16 per share (moved back into profit per share)
• Adjusted EBITDA Margin (H1 2026): approximately 12% on revenue of about €1.5b (Tessenderlo Group reported a double digit EBITDA margin in the period)

Prefer clear visuals to another wall of earnings tables and accounting footnotes? See Tessenderlo Group’s full financial picture, including a concise valuation snapshot, in the company report for Tessenderlo Group.

Tessenderlo’s Profit Rebound Starts To Match Its Growth Story

The bullish story on Tessenderlo Group is that a shift toward higher value agro products, cleaner processes and a stronger collagen platform can rebuild earnings after recent losses. H1 2026 gives some proof points. Group EBITDA of about €177m at roughly a 12% margin and a €66m net profit show the business is now earning real cash again rather than just promising a recovery.

Within Agro, a margin around 13% with volumes and pricing holding up indicates that specialty fertilizer positioning is gaining some traction even before the Swedish SOP plant from Cinis contributes. Bio valorization margins have improved after restructuring, while Industrial Solutions delivered an EBITDA margin above 10%. The agreed collagen and gelatin joint venture with Darling Ingredients plus the FMC investment and biomass cogeneration start up show Tessenderlo is taking concrete steps that align with its higher quality, more resilient earnings narrative.

Compare Tessenderlo Group’s improving margins, collagen JV plans and biomass projects with what institutional analysts are expecting. See the consensus price target analysis for Tessenderlo Group to check how those expectations line up with the current €23.3 share price.

Tessenderlo Bears Still Waiting On Cash And Integration Proof

The bearish view on Tessenderlo Group is that heavy CapEx, complex integrations and cyclical exposure could keep earnings and cash generation uneven. H1 2026 does not fully clear that hurdle. Profit returned and adjusted EBITDA reached about €177m on a 12% margin, yet net financial debt increased as the FMC stake, Cinis plant and PB Leiner buyout absorbed cash. Free cash flow is not yet a clear counter to concerns about spend-first, benefit-later projects.

Execution risk also remains on key bear milestones. The Cinis SOP plant is still pre ramp and came from a distressed situation. The collagen and gelatin joint venture with Darling Ingredients and the FMC transaction both depend on regulatory approvals that are not yet closed. Machines & Technologies is seeing weaker weaving machine demand. Tessenderlo has shown earnings repair, but the case that complex projects and integrations could slip or under-earn is not disproved by this half.

After heavy capital expenditure, rising net debt and a dividend that is not well covered by earnings, review our risk analysis for Tessenderlo Group which shows 1 important warning sign to see if these concerns are just the start of deeper structural issues.

Stay Ahead With Simply Wall St

If Tessenderlo Group’s return to profit and ongoing integration projects have your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value estimates and watch how the story develops over time. After you take a position, use the Portfolio Command Center to cut through day to day noise so you only see the key earnings, valuation and risk updates that matter for your holdings. For the longer haul, tap into the Community to compare your thesis with other investors and surface new angles on Tessenderlo Group and similar stocks. This approach can help you identify hidden catalysts and potential risks early so you can stay a step ahead of the market.

Seeking Alternatives Beyond Tessenderlo Group?

Fresh ideas move first. Markets can reward investors who identify momentum that may be under the radar before it attracts wider attention. New opportunities appear regularly, so it can be useful to review them in a timely way.

• Explore potential income-oriented candidates by scanning curated 414 dividend fortresses that aim to keep cash flows front and center while yields may still look compelling for long-term holders.
• Look for possible future growth stories by reviewing 616 high quality undiscovered gems before they attract broad attention and valuations move closer to the underlying fundamentals.
• Consider strengthening your defensive positioning by filtering for 309 resilient stocks with low risk scores that could help anchor a portfolio when momentum shifts away from higher volatility stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com